Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877)
:1877
Total Valuation
Shanghai Junshi Biosciences Co., Ltd. Class H has a market cap or net worth of HK$39.86B. The enterprise value is HK$39.83B.
Market CapHK$39.86B
Enterprise ValueHK$39.83B
Share Statistics
Shanghai Junshi Biosciences Co., Ltd. Class H has 260,295,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding260,295,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shanghai Junshi Biosciences Co., Ltd. Class H’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -8.23%.
Return on Equity (ROE)-0.14
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-8.23%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee944.05K
Profits Per Employee-330.69K
Employee Count2,578
Asset Turnover0.20
Inventory Turnover1.16
Valuation Ratios
The current PE Ratio of Shanghai Junshi Biosciences Co., Ltd. Class H is ―. Shanghai Junshi Biosciences Co., Ltd. Class H’s PEG ratio is 0.64.
PE Ratio―
PS Ratio7.92
PB Ratio3.19
Price to Fair Value3.19
Price to FCF-15.87
Price to Operating Cash Flow-80.11
PEG Ratio0.64
Income Statement
In the last 12 months, Shanghai Junshi Biosciences Co., Ltd. Class H had revenue of 2.43B and earned -851.76M in profits. Earnings per share was -0.84.
Revenue2.43B
Gross Profit1.76B
Operating Income-909.40M
Pretax Income-995.26M
Net Income-851.76M
EBITDA-599.38M
Earnings Per Share (EPS)-0.84
Cash Flow
In the last 12 months, operating cash flow was -499.69M and capital expenditures -770.61M, giving a free cash flow of -1.27B billion.
Operating Cash Flow-499.69M
Free Cash Flow-1.27B
Free Cash Flow per Share-4.88
Dividends & Yields
Shanghai Junshi Biosciences Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.59
52-Week Price Change64.30%
50-Day Moving Average21.51
200-Day Moving Average25.40
Relative Strength Index (RSI)64.44
Average Volume (3m)7.63M
Important Dates
Shanghai Junshi Biosciences Co., Ltd. Class H upcoming earnings date is Apr 28, 2026, TBA (Confirmed).
Last Earnings DateMar 13, 2026
Next Earnings DateApr 28, 2026
Ex-Dividend Date―
Financial Position
Shanghai Junshi Biosciences Co., Ltd. Class H as a current ratio of 1.60, with Debt / Equity ratio of 68.68%
Current Ratio1.60
Quick Ratio1.40
Debt to Market Cap0.21
Net Debt to EBITDA-2.55
Interest Coverage Ratio-12.37
Taxes
In the past 12 months, Shanghai Junshi Biosciences Co., Ltd. Class H has paid -13.52M in taxes.
Income Tax-13.52M
Effective Tax Rate0.01
Enterprise Valuation
Shanghai Junshi Biosciences Co., Ltd. Class H EV to EBITDA ratio is -34.69, with an EV/FCF ratio of -17.13.
EV to Sales8.54
EV to EBITDA-34.69
EV to Free Cash Flow-17.13
EV to Operating Cash Flow-44.64
Balance Sheet
Shanghai Junshi Biosciences Co., Ltd. Class H has HK$3.22B in cash and marketable securities with HK$4.14B in debt, giving a net cash position of -HK$926.89M billion.
Cash & Marketable SecuritiesHK$3.22B
Total DebtHK$4.14B
Net Cash-HK$926.89M
Net Cash Per Share-HK$3.56
Tangible Book Value Per ShareHK$5.64
Margins
Gross margin is 78.75%, with operating margin of -37.37%, and net profit margin of -35.00%.
Gross Margin78.75%
Operating Margin-37.37%
Pretax Margin-40.89%
Net Profit Margin-35.00%
EBITDA Margin-24.63%
EBIT Margin-37.37%
Analyst Forecast
The average price target for Shanghai Junshi Biosciences Co., Ltd. Class H is HK$33.35, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$33.35
Price Target Upside33.72% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast38.56%
EPS Growth Forecast48.26%